Activins and follistatins: Emerging roles in liver physiology and cancer

doi:10.4254/wjh.v1.i1.17

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6633)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

632

HTML

5680

Figures (1-2)

321

Sum=6633

Oct 31, 2009 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (33)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Guidelines For Basic Science

World J Hepatol. Oct 31, 2009; 1(1): 17-27
Published online Oct 31, 2009. doi: 10.4254/wjh.v1.i1.17

Full Size Figure Download Figure

Figure 1 Number and arrangement of follistatin/Kazal-like domains in follistatin-like proteins. SP: Signal peptide; FS: Follistatin/Kazal-like domain; EF: EF-hand domain; VWFC: von Willebrand factor type C repeat; IGFBP: IGF-binding protein N-terminal domain; Ig: Immunoglobulin-like domain. Text to the right shows the number of amino acids (aa), most common name(s) and Uniprot accession number.

Citation: Kreidl E, Öztürk D, Metzner T, Berger W, Grusch M. Activins and follistatins: Emerging roles in liver physiology and cancer. World J Hepatol 2009; 1(1): 17-27
URL: https://www.wjgnet.com/1948-5182/full/v1/i1/17.htm
DOI: https://dx.doi.org/10.4254/wjh.v1.i1.17